Cargando…
Identification of a methylomics-associated nomogram for predicting overall survival of stage I–II lung adenocarcinoma
The aim of this paper was to identify DNA methylation based biomarkers for predicting overall survival (OS) of stage I–II lung adenocarcinoma (LUAD) patients. Methylation profile data of patients with stage I–II LUAD from The Cancer Genome Atlas (TCGA) database was used to determine methylation site...
Autores principales: | Wang, Heng, Wei, Chuangye, Pan, Peng, Yuan, Fengfeng, Cheng, Jiancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113535/ https://www.ncbi.nlm.nih.gov/pubmed/33976305 http://dx.doi.org/10.1038/s41598-021-89429-4 |
Ejemplares similares
-
A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
por: Wei, Xuan, et al.
Publicado: (2023) -
Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020) -
An immune-related nomogram model that predicts the overall survival of patients with lung adenocarcinoma
por: Sun, Jing, et al.
Publicado: (2022) -
A novel nomogram to predict the overall survival of patients with colloid adenocarcinoma of the lung
por: Zhang, Jun, et al.
Publicado: (2021) -
Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma
por: Yan, Qian, et al.
Publicado: (2019)